Objective <p>To assess current practices in the diagnosis, monitoring, and follow-up of neonatal AKI across Canadian tertiary neonatal units.</p> Study design <p>A seven-item electronic survey was distributed to members of the Canadian Neonatal Network between December 2023 and January 2024.</p> Results <p>Of the 32 units contacted, 26 (81.3%) responded. On-site nephrology consultation was available at 15/26 sites (57.7%). Only 5 sites (19.2%) actively tracked AKI incidence in infants born &lt; 33 weeks’ gestation. Wide variation was observed in AKI definitions, monitoring practices, and follow-up protocols. Serum creatinine was measured prior to initiating non-steroidal anti-inflammatory drugs at 15 sites (57.7%), and 11 sites (42.3%) monitored creatinine when urine output fell below 0.5 mL/kg/hour.</p> Conclusions <p>Substantial variability exists in the identification and monitoring of neonatal AKI among Canadian NICUs. Standardized diagnostic criteria and follow-up strategies are needed to improve early detection and optimize long-term renal outcomes.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Neonatal acute kidney injury: a survey of practices in Canadian neonatal intensive care units

  • Abbeir Hussein,
  • Linda Ding,
  • Kyong-Soon Lee,
  • Cherry Mammen,
  • Marc Beltempo,
  • Prakesh S. Shah,
  • Po-Yin Cheung,
  • Catherine Morgan,
  • Joseph Y. Ting,
  • Marc Beltempo,
  • Prakesh S. Shah,
  • Thevanisha Pillay,
  • Jonathan Wong,
  • Miroslav Stavel,
  • Rebecca Sherlock,
  • Ayman Abou Mehrem,
  • Jennifer Toye,
  • Joseph Y. Ting,
  • Carlos Fajardo,
  • Andrei Harabor,
  • Lannae Strueby,
  • Mary Seshia,
  • Deepak Louis,
  • Chelsea Ruth,
  • Ann Yi,
  • Amit Mukerji,
  • Orlando Da Silva,
  • Sajit Augustine,
  • Kyong-Soon Lee,
  • Eugene Ng,
  • Brigitte Lemyre,
  • Brigitte Lemyre,
  • Faiza Khurshid,
  • Victoria Bizgu,
  • Keith Barrington,
  • Anie Lapointe,
  • Guillaume Ethier,
  • Christine Drolet,
  • Martine Claveau,
  • Marie St-Hilaire,
  • Valerie Bertelle,
  • Edith Masse,
  • Caio Barbosa de Oliveira,
  • Hala Makary,
  • Gabriela de Carvalho Nunes,
  • Wissam Alburaki,
  • Jo-Anna Hudson,
  • Jehier Afifi,
  • Andrzej Kajetanowicz,
  • Bruno Piedboeuf

摘要

Objective

To assess current practices in the diagnosis, monitoring, and follow-up of neonatal AKI across Canadian tertiary neonatal units.

Study design

A seven-item electronic survey was distributed to members of the Canadian Neonatal Network between December 2023 and January 2024.

Results

Of the 32 units contacted, 26 (81.3%) responded. On-site nephrology consultation was available at 15/26 sites (57.7%). Only 5 sites (19.2%) actively tracked AKI incidence in infants born < 33 weeks’ gestation. Wide variation was observed in AKI definitions, monitoring practices, and follow-up protocols. Serum creatinine was measured prior to initiating non-steroidal anti-inflammatory drugs at 15 sites (57.7%), and 11 sites (42.3%) monitored creatinine when urine output fell below 0.5 mL/kg/hour.

Conclusions

Substantial variability exists in the identification and monitoring of neonatal AKI among Canadian NICUs. Standardized diagnostic criteria and follow-up strategies are needed to improve early detection and optimize long-term renal outcomes.